UHS Stock Forecast & Price Target

Universal Health Services is expected to benefit from strong behavioral volume growth, which accounts for over 55% of pretax profits and is projected to accelerate towards the company's 2-3% target. The company has also demonstrated positive performance in its acute care services, driven by high acuity procedures and favorable pricing. While uncertainties around policy dynamics and execution risks remain, we expect UHS to achieve core EBITDA growth and potentially exceed its current year guidance, with a price target of $190 based on a discounted multiple of 5.75x 2027 adjusted EBITDA-NCI estimate.

Universal Health Services is facing significant headwinds in its core business as evidenced by its 1Q26 results which saw core EBITDA decline around 4%, well below management's target of 5% growth for the year. The company is facing multiple challenges such as seasonal effects, flu and weather impacts, and tightening of labor supply which could continue to weigh on its financial performance. Additionally, the company's recent sustainability initiatives and the acquisition of Talkspace are unlikely to provide significant relief in the near term. These factors, combined with the current regulatory and competitive landscape, lead to a negative outlook on Universal Health Services' stock.